Contrast Induced Acute Kidney in Patients With Acute Stroke

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03132558

Enrollment

200

Registered

2017-04-28

Start date

2016-09-30

Completion date

2017-12-31

Last updated

2017-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Acute

Brief summary

Computed tomographic angiography (CTA) is recommended for identifying eligible patient with acute ischemic stroke (AIS) to receieve endovascular treatment. We are going to conduct this prospective corhot study to observe if sequential use contrast in CTA examination and in endovascular treatment will cause acute kidney injury.

Interventions

DRUGRadiopaque Media

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* All patients who are suspected with AIS. * Non-contrast head CT excludes intracranial hemorrhage.

Exclusion criteria

* Lacking of pre-CTA Creatinine * Lacking of post-angiography Creatinine with 24-48 hours

Design outcomes

Primary

Measure	Time frame	Description
Creatinine	within 24h to 48h	Contrast-induced acute kidney injury was defined as a relative increase of 25% or an absolute increase of 0.3 mg/dL (28.2mol/L) in the serum creatinine level at 48 hours following angiography

Countries

China

Contacts

Primary ContactHaiBin Shi, MD.

shihb@njmu.edu.cn

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026